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Proteins with multiple binding sites play important roles in cell signaling systems by nucleating
protein complexes in which, for example, enzymes and substrates are co-localized. Proteins that
specialize in this function are called by a variety names, including adapter, linker and scaffold.
Scaffold-mediated nucleation of protein complexes can be either constitutive or induced. Induced
nucleation is commonly mediated by a docking site on a scaffold that is activated by phosphoryla-
tion. Here, by considering minimalist mathematical models, which recapitulate scaffold effects seen
in more mechanistically detailed models, we obtain analytical and numerical results that provide
insights into scaffold function. These results elucidate how recruitment of a pair of ligands to a
scaffold depends on the concentrations of the ligands, on the binding constants for ligand-scaffold
interactions, on binding cooperativity, and on the milieu of the scaffold, as ligand recruitment is
affected by competitive ligands and decoy receptors. For the case of a bivalent scaffold, we obtain
an expression for the unique scaffold concentration that maximally recruits a pair of monovalent
ligands. Through simulations, we demonstrate that a bivalent scaffold can nucleate distinct sets
of ligands to equivalent extents when the scaffold is present at different concentrations. Thus, the
function of a scaffold can potentially change qualitatively with a change in copy number. We also
demonstrate how a scaffold can change the catalytic efficiency of an enzyme and the sensitivity
of the rate of reaction to substrate concentration. The results presented here should be useful for
understanding scaffold function and for engineering scaffolds to have desired properties.
Keywords: multivalent binding, synthetic biology, biological design principles, ternary complex, prozone
effect, combinatorial inhibition, adaptor
I. INTRODUCTION
Proteins involved in cell signaling typically possess
multiple binding sites, and as a result, a common fea-
ture of these proteins is their ability to interact with sev-
eral binding partners to form heterogeneous protein com-
plexes [1]. Some proteins specialize in the nucleation of
protein complexes [2]. For example, Ste5 is a well-studied
scaffold protein that acts in a yeast MAP kinase cascade;
it binds all three kinases of the cascade, Ste11, Ste7, and
Fus3 [3]. The interaction of Fus3 with Ste5 is modulated
by multisite phosphorylation of Ste5 [4]. One function of
Ste5 is to co-localize enzyme-substrate pairs (e.g., Ste11
and Ste7) in the cascade [5], which contributes to switch-
like cellular responses to signals [4]. Two well-known
examples of scaffold-like proteins that nucleate protein
complexes in mammalian signaling systems are the Grb2
adapter protein in the epidermal growth factor receptor
(EGFR) pathway [6] and the LAT linker protein in the
T cell receptor (TCR) pathway [7–9]. The binding sites
in LAT are activated by tyrosine phosphorylation, and
as a result, the valence of LAT and the abundance of
functional LAT binding sites can be quickly changed by
changes in kinase and phosphatase activities, with these
changes serving to modulate the effect of LAT on signal-
ing [10]. In addition to proteins with dedicated scaffold
functions, proteins that have catalytic activities and pro-
tein complexes, such as ligand-induced receptor dimers,
can also function as scaffolds, i.e., take on the function of
facilitating the formation of multicomponent complexes
through multivalent binding.
Many functions have been ascribed to scaffold pro-
teins [2, 9, 11–14]. For example, scaffolds have been
suggested to control the specificities of enzymes, coor-
dinate spatiotemporal aspects of signaling, and amplify
or attenuate signals. To better understand the mech-
anisms by which scaffolds influence cell signaling, re-
searchers have formulated mathematical models to study
the effects of scaffolds on specific signaling systems and
to study the generic properties of scaffolds [4, 15–22].
The ability of a scaffold to either amplify or attenuate
signaling was demonstrated by Levchenko et al. [16] us-
ing a mathematical model for a MAP kinase cascade.
In this model, scaffold enhancement of signaling results
from scaffold-mediated nucleation of an enzyme with
its substrate, whereas scaffold inhibition of signaling re-
sults from excess scaffold, which separates enzyme and
substrate into distinct enzyme-scaffold and substrate-
scaffold complexes. This effect is equivalent to the well-
known prozone effect in antibody-antigen reactions [15].
Heinrich et al. [17] further studied these effects of scaf-
folds on protein kinase cascades. More recently, Locasale
et al. [20] studied how scaffolds affect competition be-
tween phosphatases and kinases, finding that scaffolds
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2can have positive and negative effects on signaling for
reasons related to the kinetics of signaling events.
Modeling has improved our understanding of scaffold
function, but many of the reported modeling studies of
scaffold function have been based solely on simulations,
which makes the results dependent on the parameter val-
ues considered in simulations. In addition, many of the
models used to study scaffolds incorporate mechanistic
details that are likely to be extraneous for understand-
ing scaffold function broadly. Greater theoretical under-
standing of the design principles of scaffolds could per-
haps be obtained by focusing on minimalist models that
are relatively easy to analyze. With a better understand-
ing of scaffold design principles, we can hope to manip-
ulate scaffold function through precise tuning of scaffold
and system properties. Manipulating the properties of a
scaffold or its milieu to alter the behavior of a cell sig-
naling system is known to be feasible [5, 23, 24]. For ex-
ample, Lim and co-workers have demonstrated that the
response of a cell to a signal can be changed qualitatively
by altering the binding specificities of a scaffold [5].
Here, by considering minimalist models for multiva-
lent scaffold-ligand interaction, we investigate the re-
cruitment of ligands to a scaffold and the effects of a
scaffold on an enzymatic reaction. We obtain a number
of analytical and numerical results, mostly for a model
that characterizes the equilibrium formation of a ternary
complex composed of a scaffold and two binding part-
ners. In this ternary-complex model, the scaffold is biva-
lent and and its monovalent binding partners are taken
to be an enzyme-substrate pair. Each binding partner,
or ligand, interacts with one of the two binding sites of
the scaffold. We evaluate the relevance of the ternary-
complex model through comparisons with more mecha-
nistically detailed models for cell signaling systems that
involve scaffolds. The ternary-complex model is similar
in mathematical form to a variety of models that have
been used to study receptor signaling [25, 26] and multi-
valent ligand-receptor binding [27–29].
The remainder of this report is organized as follows.
In Section II, we introduce models and present analytical
results relevant for understanding the effects of scaffold
valence, negative and positive cooperativity in binding
of multiple ligands to a scaffold, competitive inhibitors of
ligand-scaffold interactions, and decoy receptors. We also
develop an approximate rate law for scaffold-mediated
enzyme kinetics. Our most significant analytical result
is a design equation that characterizes how the scaffold
concentration that maximally nucleates a ternary com-
plex depends on equilibrium binding constants and lig-
and concentrations. Interestingly, this scaffold concen-
tration is independent of cooperativity in ligand binding.
In Section III, we present numerical results that comple-
ment the analytical results. The numerical results in-
clude a demonstration that our simple ternary-complex
model recapitulates scaffold effects seen in more mech-
anistically detailed models and a demonstration that a
single scaffold can nucleate distinct signaling complexes
CA
a b
A B
B
a
AI D
S1 S2 Sn...
L1 L2 Ln...
D
C
a
 + B
C
b
 + A
S
+ A
+ B
C
ab
 
k a
 
k -a
 
k
b  
k
-b  
hk
cat
 
k a
 
k -a
 
k
b  
k
-b  
A' + C
b
 
...
FIG. 1. Minimalist models for ligand-scaffold interactions.
(A) A scaffold with n sites (S1, . . . , Sn). Each site Si interacts
with a distinct ligand Li. (B) Ternary-complex model. A
bivalent scaffold with sites a and b interacts with monovalent
ligands A and B, respectively. (C) A scaffold site a interacts
with a ligand A and a competitive inhibitor I. The ligand
A interacts with a decoy receptor D. (D) A reaction scheme
for a scaffold-mediated enzymatic reaction that produces a
product A′. The substrate is scaffold ligand A and the enzyme
is scaffold ligand B. See text for discussion.
at different scaffold concentrations. We conclude with a
brief discussion (Section IV).
II. MODELS AND ANALYTICAL RESULTS
The models that we will consider are illustrated in
Fig. 1 and described below, along with various analyt-
ical results relevant for understanding scaffold function.
A. Multivalent scaffold with independent binding
sites
We consider a scaffold protein with n ≥ 2 binding sites.
Each scaffold binding site i interacts independently with
a distinct monovalent ligand i, as illustrated in Fig. 1(A).
Thus, we consider the following reactions:
Si + Li ⇀↽ Bi, i = 1, . . . , n , (1)
where Si represents free site i, Li represents free ligand
i, and Bi represents bound site i (or equivalently, bound
ligand i). Using the same symbols for chemical species
in Eq. (1) for the corresponding concentrations, we can
write the following equilibrium relations, which are de-
rived from the law of mass action:
KiBi = SiLi, i = 1, . . . , n , (2)
where Ki is an equilibrium dissociation constant. As-
suming conservation of mass, such that S0 = Si + Bi
3and Li0 = Li + Bi, where S0 is the total concentration
of scaffold protein and Li0 is the total concentration of
ligand i, we find from Eq. (2) that
B2i − (S0 + Li0 +Ki)Bi + S0Li0 = 0 . (3)
From the quadratic formula and the physical constraint
that Bi < min(Li0 , S0), it further follows that
Bi =
S0 + Li0 +Ki −
√
(S0 + Li0 +Ki)
2 − 4S0Li0
2
.
(4)
This equation and the mass conservation relations given
above can be used to completely determine the equilib-
rium state of the system described in Fig. 1(A).
We will now show that there is a unique scaffold con-
centration Sopt0 that maximizes Cn, the equilibrium con-
centration of scaffold protein with all n sites occupied.
The analytical results that follow complement numerical
results obtained in earlier modeling studies of scaffold
function [11, 15–17].
We note that the equilibrium quantity Bi/S0 can be
interpreted as the probability that scaffold binding site
i is occupied at equilibrium. Likewise, Cn/S0 can be
interpreted as the joint probability that all n scaffold
binding sites are occupied. Thus, because each scaffold
binding site is assumed to interact with its cognate ligand
independently, we can write
Cn = S
1−n
0
n∏
i=1
Bi . (5)
Trivially, for the case S0 = 0, Cn = 0. In other words,
there is no complex in the absence of scaffold. Also, from
Eq. (5), we can see that limS0→∞ Cn = 0, because each
Bi is finite. In fact Bi can be no greater than Li0 . From
inspection of Eqs. (4) and (5), one can see that Cn is a
continuous and differential function of S0. Thus, from the
mean value theorem, the derivative of Cn with respect to
S0 must vanish at some finite value of S0, which we will
denote as Sopt0 . In other words,
dCn
dS0
∣∣∣∣
S0=S
opt
0
= 0 . (6)
Because Sopt0 is unique, as we will show below, and Cn
is positive for all finite S0 (on physical grounds), Cn is
maximum at S0 = S
opt
0 .
To see that Sopt0 is unique, consider the following ex-
pression, which is derived from Eq. (5) by differentiating
Cn with respect to S0:
gn ≡ S0
Cn
dCn
dS0
=
n∑
i=1
bi − (n− 1) , (7)
where
bi ≡ S0
Bi
dBi
dS0
=
S0(Bi − Li0)
B2i − S0Li0
. (8)
Note that gn is the slope of the plot of logCn vs. logS0.
The expression for bi was obtained by differentiating each
term in Eq. (3) with respect to S0 and then solving for
dBi/dS0. From inspection of Eq. (8), one can see that
0 < bi < 1 for finite S0. In fact, it can be shown that
limS0→0 bi = 1 and limS0→∞ bi = 0. From these consid-
erations and inspection of Eq. (7), one can see that Sopt0
is unique if bi decreases monotonically as S0 increases for
all i. Differentiating the expression for bi given in Eq. (8)
with respect to S0, we find
dbi
dS0
=
Bi(Bi − Li0)(Bi − S0)(B2i + S0Li0)
(B2i − S0Li0)3
< 0 . (9)
Note that the terms Bi−Li0 , Bi−S0, and B2i −S0Li0 are
all negative. Thus, each bi is a monotonically decreasing
function, as is gn by extension, and as a result, S
opt
0 is
unique.
The results presented above provide insight into the
shape of the log-log scaffold dose-response curve, mean-
ing the plot of logCn vs. logS0. Recall that the slope
of this curve, which is concave, is given by Eq. (7). As
can be seen from Eq. (7), for S0 < S
opt
0 , 1 > gn > 0,
whereas for S0 > S
opt
0 , 0 > gn > 1 − n. For n = 2, |g2|
approaches 1 as S0 approaches either 0 or ∞. However,
for n ≥ 3, the two asymptotic limits of |gn| are different,
with the curve becoming steeper at some point in the
excess scaffold regime (S0 > S
opt
0 ) than at any point in
the regime where S0 < S
opt
0 . Thus, the log-log scaffold
dose-response curve is asymmetric.
To gain insight into the effect of scaffold valence on
scaffold function, measured by nucleation of a complex
in which all scaffold binding sites are occupied, let us
consider two scaffolds in the same milieu with the same
properties except that one scaffold has an extra bind-
ing site n and cognate binding partner Ln. We impose
this equivalence constraint to ensure a fair comparison
[30, 31]. We will denote the valences of the two scaffolds
as m ≥ 2 and n = m + 1. From Eq. (5) and our equiv-
alence constraint, it follows that Cn = CmBn/S0 and
further that Cn < Cm for any given scaffold concentra-
tion. Thus, with all factors being as equal as possible,
scaffold-mediated nucleation of Cn is less efficient than
nucleation of Cm. Another inherent effect of valence on
scaffold function is greater sensitivity of Cn to changes
in scaffold concentration in the excess scaffold regime.
From Eq. (7), for S0 sufficiently large such that gm < 0
and gn < 0, it can be seen that gn is larger in magnitude
than gm. This result is consistent with our earlier discus-
sion of asymmetry in the log-log scaffold dose-response
curve.
B. Bivalent scaffold with cooperative ligand
binding
We will now consider a bivalent scaffold that interacts
with a pair of monovalent ligands A and B (Fig. 1(B)).
4Ligand A interacts with a scaffold binding site a, and
ligand B interacts with a scaffold binding site b. Equa-
tion (1) with n = 2 applies, but we will not use the
nomenclature of Eq. (1) in our treatment of this spe-
cial case, which because of its simplicity will allow us to
obtain an analytical expression for the scaffold concen-
tration that maximizes formation of the ternary complex
composed of A, B and the scaffold. Nucleation of this
complex can be taken as a measure of the functional ac-
tivity of the scaffold if A and B constitute an enzyme and
substrate or if instead the two ligands constitute func-
tionally related enzymes recruited to the scaffold to act
in concert, as in substrate channeling [32]. We will re-
lax the assumption that ligands interact with the scaffold
independently and allow for cooperative binding. Thus,
using the law of mass action, we write the following equi-
librium relations:
KaCa = SfAf , (10)
KbCb = SfBf , (11)
KaCab = φAfCb . (12)
where Sf is the concentration of free scaffold, Af and Bf
are the concentrations of free ligands A and B, Ka is an
equilibrium dissociation constant that characterizes a-A
interaction, Ca is the concentration of the binary com-
plex composed of A and the scaffold, Kb is an equilibrium
dissociation constant that characterizes b-B interaction,
Cb is the concentration of the binary complex composed
of B and the scaffold, and Cab is the concentration of
the ternary complex composed of A, B, and the scaf-
fold. The factor φ, which is positive and dimensionless,
is introduced to characterize cooperativity in binding of
A and B to the scaffold: φ < 1 indicates negative co-
operativity, φ > 1 indicates positive cooperativity, and
φ = 1 indicates that the ligands bind the scaffold inde-
pendently. We will assume conservation of mass, such
that the following relations hold:
S0 = Sf + Ca + Cb + Cab , (13)
A0 = Af + Ca + Cab , (14)
B0 = Bf + Cb + Cab . (15)
where S0 is the total scaffold concentration, A0 is the
total concentration of ligand A, and B0 is the total con-
centration of ligand B.
We will now derive an expression for Sopt0 , the
total scaffold concentration that maximizes Cab, or
equivalently, the total scaffold concentration for which
dCab/dS0 = 0. From Eqs. (10) and (12), we find
Cab = φ
CaCb
Sf
. (16)
We note that, for φ = 1, Cab = CaCb/Sf = (Ca +
Cab)(Cb + Cab)/S0, which is equivalent to Eq. (5) with
n = 2. From Eqs. (10) and (14), we find
Ca =
Sf (A0 − Cab)
Sf +Ka
. (17)
Similarly, from Eqs. (11) and (15), we find
Cb =
Sf (B0 − Cab)
Sf +Kb
. (18)
From Eqs. (16)–(18), we find
C2ab −RCab +A0B0 = 0 , (19)
where
R ≡ A0 +B0 + (Sf +Ka)(Sf +Kb)/(φSf ) . (20)
Differentiating each term in Eq. (19) with respect to S0,
we find
dCab
dS0
=
(
Cabφ
−1
2Cab −R
)(
1− KaKb
S2f
)
dSf
dS0
. (21)
From this equation, one can see that the derivative
dCab/dS0 uniquely vanishes at Sf =
√
KaKb. Thus, S
opt
0
is the value of S0 at which Sf =
√
KaKb. Using Eqs. (17)
and (18), we can rewrite Eq. (13) as follows:
S0 = Sf+
SfA0
Sf +Ka
+
SfB0
Sf +Kb
+
(
1− Sf
Sf +Ka
− Sf
Sf +Kb
)
Cab .
(22)
Substituting
√
KaKb for Sf in Eq. (22), we find
Sopt0 =
√
KaKb +
A0
1 +
√
Ka/Kb
+
B0
1 +
√
Kb/Ka
. (23)
Notably, Sopt0 is independent of the cooperativity factor
φ. For the special case Ka = Kb = KD, S
opt
0 = KD +
(A0 +B0)/2. For the special case A0 = B0 = L0, S
opt
0 =√
KaKb + L0.
It is straightforward to find an expression for the max-
imum concentration of scaffold-nucleated ternary com-
plex, which we will denote as Cmaxab . We simply use the
quadratic formula to solve Eq. (19) for the case where
R = A0 + B0 + φ
−1(
√
Ka +
√
Kb)
2. This expression for
R is obtained by substituting
√
KaKb for Sf in Eq. (20).
Unlike Sopt0 , C
max
ab depends on φ (because R depends on
φ). For the special case where φ = 1, Ka = Kb = KD and
A0 = B0 = L0, we find C
max
ab = (
√
KD + L0 −
√
KD)
2.
C. Effect of a competitor or decoy receptor
The in vivo milieu of a scaffold is complex. A given
binding site on the scaffold may interact with a specific
ligand as well as a number of competitors. Likewise, the
ligand may interact a number of binding partners be-
sides the scaffold. To study the effects of the milieu on
the function of a scaffold, we consider the simple scenario
illustrated in Fig. 1(C). A ligand A interacts with a scaf-
fold binding site a in competition with an inhibitor I.
5The ligand also interacts with a decoy receptor D. Thus,
we consider the following equilibrium relations:
KaBa = SaAf , (24)
KcBc = SaIf , (25)
KdBd = DfAf , (26)
where Sa is the concentration of free scaffold binding site
a, Af is the concentration of free ligand A, Ba is the con-
centration of scaffold bound to ligand A, If is the con-
centration of free inhibitor I, Bc is the concentration of
scaffold bound to competitive inhibitor I, Df is the con-
centration of free decoy receptor D, and Bd is the concen-
tration of ligand A bound to decoy receptor D. The equi-
librium dissociation constants Ka, Kc and Kd character-
ize a-A interaction, a-I interaction and A-D interaction,
respectively. We will assume that the following mass con-
servation relations hold: S0 = Sa +Ba +Bc, where S0 is
the total scaffold concentration, and A0 = Af +Ba+Bd,
where A0 is the total ligand concentration.
To quantify the effect of a competitive inhibitor or de-
coy receptor on interaction between a scaffold binding
site and a ligand, we can find the apparent equilibrium
dissociation constant K ′a satisfying the relation K
′
aBa =
S′aA
′
f (cf. Eq. (24)), where S
′
a ≡ S0 − Ba = Sa + Bc is
the apparent concentration of free scaffold binding site a
and A′f ≡ A0 − Ba = Af + Bd is the apparent concen-
tration of free ligand A. From these considerations and
Eqs. (24)–(26), we find
K ′a = Ka
(
1 +
If
Kc
)(
1 +
Df
Kd
)
. (27)
Thus, a competitive inhibitor or decoy receptor simply
has the effect of reducing the apparent affinity of a ligand
for its scaffold binding site.
In the previous section, we provided equations that elu-
cidate how Sopt0 and C
max
ab depend on binding constants.
Given Eq. (27), we can now interpret these equations as
also defining how competitive inhibitors and decoy recep-
tors in the milieu of a scaffold affect Sopt0 and C
max
ab . A
competitive inhibitor or decoy receptor can shift the total
scaffold concentration that maximally nucleates a signal-
ing complex. For example, under certain conditions, a
competitive inhibitor can promote scaffold-mediated nu-
cleation of a signaling complex by reversing the effect of
excess scaffold (i.e., the effect of S0 > S
opt
0 ). Thus, the
function of a scaffold might be controlled by regulating
the expression levels of competitive inhibitors and decoy
receptors. It should also be noted that competitive in-
hibitors and decoy receptors can obscure the relationship
between Sopt0 in vivo and binding parameters determined
in vitro.
D. Effect of a scaffold on the rate of an
enzyme-catalyzed reaction
To study the effect of a scaffold on the rate of an
enzyme-catalyzed reaction, we consider the scheme pre-
sented in Fig. 1(D). This scheme represents a sim-
ple extension of the classical Michaelis-Menten reaction
scheme:
A+B
k1⇀↽
k−1
(AB)
kcat→ A′ +B , (28)
where A is a substrate, B is an enzyme, (AB) is an
enzyme-substrate complex, A′ is a product, and k1,
k−1 and kcat are rate constants. As is well known, a
pseudo steady-state assumption leads to the following
approximate expression for the rate of product formation
V ≡ kcat(AB):
V =
kcatB0Af
Km +Af
, (29)
where Af is the concentration of free substrate, B0 is the
total concentration of enzyme, andKm = (k−1+kcat)/k1.
For simplicity, we will assume that kcat  k−1 such that
Km ≈ k−1/k1. When Km is set equal to k−1/k1, it can
be said that Eq. (29) depends on a rapid equilibrium
assumption.
To obtain an expression analogous to that of Eq. (29)
for the reaction scheme of Fig. 1(D), we will assume
that V ′, the rate of product formation when an en-
zyme and substrate are co-localized on a scaffold, is
proportional the concentration of the ternary complex
of the scaffold, enzyme and substrate, which we will
denote as Cab. In other words, we will assume that
V ′ ≡ hkcatCab = hkcat(B0 − Bf − Cb), where h ≥ 0
is a constant introduced to characterize the effect on re-
activity of scaffold-controlled positioning of the enzyme
and substrate. Positioning/orientation of an enzyme-
substrate pair is a known function of some scaffolds [14].
Note that we have assumed conservation of enzyme, such
that B0 = Bf + Cb + Cab, where B0 is the total concen-
tration of enzyme, Bf is the concentration of free en-
zyme, and Cb is the concentration of the binary complex
of enzyme and scaffold (Fig. 1(D)). Under a rapid equi-
librium assumption, we take the following relations to
hold: KbCb = SfBf and KaCab = AfCb, where Sf is the
concentration of free scaffold and Ka and Kb are equi-
librium dissociation constants. Note that Ka = k−a/ka
and Kb = k−b/kb, where ka, k−a, kb and k−b are rate
constants in the reaction scheme of Fig. 1(D). Thus,
V ′ =
hkcatB0Af
K ′m +Af
, (30)
where K ′m = Ka(1 + Kb/Sf ). If h in Eq. (30) is ap-
proximately 1 (i.e., scaffold effects on the reactivity of
scaffold-tethered enzyme and substrate are inconsequen-
tial, which can be the case [5]), then the effect of a scaffold
on the rate of an enzyme-catalyzed reaction lies in the dif-
ference between Km and K
′
m, the apparent Micheaelis-
Menten constant for the scaffold-mediated reaction. Note
that K ′m is unrelated to Km and is determined by the
affinities of the enzyme and substrate for binding sites
on the scaffold and by the concentration of free scaffold.
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FIG. 2. Comparison of predictions of the ternary-complex
model and more mechanistically detailed models capturing
the effects of scaffolds. (A) Comparison between the results of
the ternary-complex model (solid line) and a model for a MAP
kinase cascade incorporating a scaffold [16]. The broken line
corresponds to the concentration of phosphorylated MAPK
in Ref. [16]. Parameter values correspond to those used in
Ref. [16]: A0 = 0.2 µM, B0 = 0.4 µM and Ka = Kb =
5 nM. (B) Comparison between the results of the ternary-
complex model (solid line) and a model for early events in
IgE receptor signaling [33, 34]. The broken line corresponds
to the amount of Syk autophosphorylation predicted by the
model of Ref. [34] for the case of 4 × 104 Syk molecules per
cell, as in Fig. 3 of Ref. [1]. Other parameter values are as in
Ref. [34]. Note that theKD for Syk binding to phosphorylated
receptor is 2167 molecules per cell.
Thus, a scaffold can profoundly affect the catalytic ef-
ficiency of an enzyme even if the stereochemical effects
of the scaffold on reactivity (captured in h) are inconse-
quential.
III. NUMERICAL RESULTS
A. Relevance of simple ternary-complex model
To investigate scaffold-mediated nucleation of signal-
ing complexes, we will focus, except as noted, on a biva-
lent scaffold that recruits a pair of monovalent ligands,
i.e., on our ternary-complex model given by Eqs. 10–15
and illustrated in Fig. 1(B). To demonstrate the rele-
vance of this minimalist model, we will consider two more
mechanistically detailed models for cell signaling systems
reported in the literature. The first of these models char-
acterizes the effect of a scaffold on a MAP kinase cas-
cade [16]. The second model characterizes early events
of immunoreceptor signaling, in which a ligand-induced
receptor dimer nucleates a signaling complex [33, 34].
In the model of Levchenko et al. [16], MAPK is phos-
phorylated as a result of a cascade of binding and phos-
phorylation reactions in which a scaffold co-localizes
MAPK with its kinase, MAPKK. In Fig. 2A, we plot
the steady-state level of phosphorylation of MAPK pre-
dicted by the model of Levchenko et al. [16] as a function
of scaffold concentration. In addition, we plot the de-
pendence of scaffold-nucleated ternary complex concen-
tration (Cab) on scaffold concentration using the param-
eters that characterize the binding reactions of MAPK,
MAPKK and scaffold in the original model. As can be
seen, if we assume that MAPK phosphorylation is re-
lated to the amount of MAPK and MAPKK co-localized
by scaffold, then our simple model closely predicts the
steady-state level of MAPK phosphorylation predicted
by the model of Levchenko et al. [16] even though the
simple model omits many of the reactions included in
the more mechanistically detailed model. This result
suggests that the steady-state output of the MAP ki-
nase cascade is dominated by co-localization of MAPK
and MAPKK by the scaffold. We note that the MAPK-
scaffold and MAPKK-scaffold equilibrium dissociation
constants in the model of [16] are each 5 nM. As a re-
sult, Sopt0 is largely determined by the concentrations of
MAPK (0.4 µM) and MAPKK (0.2 µM), as can be seen
from Eq. (23).
In the mechanistic model for early events in IgE recep-
tor (FcRI) signaling developed by Goldstein et al. [33]
and Faeder et al. [34], a bivalent ligand induces recep-
tor dimerization; receptor phosphorylation; recruitment
of Syk, a cytosolic protein tyrosine kinase, to phospho-
rylated receptors; and autophosphorylation of receptor-
associated Syk. In this model, a phosphorylated recep-
tor dimer acts as a scaffold that co-localizes two copies
of Syk, enabling one copy of Syk to phosphorylate its
neighboring copy of Syk. In Fig. 2B, we plot the steady-
state level of Syk autophosphorylation predicted by the
detailed model with the parameters of Ref. [34] as a
function of receptor dimer concentration. We also plot
the dependence of Cab on phosphorylated receptor dimer
(the effective scaffold) concentration using the parame-
ters of Ref. [34] that characterize the binding reactions of
phosphorylated receptor and Syk. As can be seen, if we
assume that Syk autophosphorylation is related to the
number of receptor dimers associated with two copies of
Syk, then the ternary-complex model accurately predicts
the amount of ligand-induced receptor dimers that yields
maximum Syk autophosphorylation. This result further
demonstrates that the minimalist ternary-complex model
can provide insights into the effects of a scaffold on cell
signaling.
We caution that the ternary-complex model is not
7guaranteed to recapitulate the system properties of more
sophisticated, more mechanistic models. Our point is
only that the model, despite its simplicity, can be use-
ful for gaining insights into signaling events in which
scaffold-mediated nucleation plays a role, as illustrated
by the qualitative similarities of the two sets of curves
in Fig. 2. The ternary-complex model can fail to cap-
ture the effects of a scaffold in the context of a specific
cell signaling system for myriad reasons. For example,
an important caveat of the model is that it is an equi-
librium model. Thus, if interactions of binding partners
with a scaffold are slow relative to the time scale of pro-
cesses affected by scaffold-mediated nucleation, then the
ternary-complex model will fail to capture the true ef-
fects of the scaffold, which will be dominated by the ki-
netics of ligand-scaffold interactions. Also, the scope of
the ternary-complex model is rather circumspect. For
example, it does not account for the process of Syk de-
phosphorylation in the model of Refs. [33, 34], or more
generally, downstream influences on events triggered by
scaffold-mediated nucleation. This feature of the ternary-
complex model (e.g., omission of processes affecting Syk
phosphorylation status, including dephosphorylation me-
diated by phosphatases) explains the quantitative dis-
crepancy between the two curves of Fig. 2(B).
B. Concentration-dependent scaffold functionality
A bivalent scaffold, depending on its concentration,
can recruit different pairs of ligands. In Fig. 3A, we show
that two ligand pairs can be recruited to the same scaf-
fold and to the same maximal extent at different scaf-
fold concentrations. Co-localization of the first ligand
pair is maximum at a scaffold concentration of 0.055 µM,
whereas co-localization of the second ligand pair is max-
imum at 9.8 µM. In general, such a scenario requires
that the ligand pairs have different total concentrations
and/or scaffold affinities (Fig. 3B). The contour plot of
Fig. 3B shows how Cmaxab , the concentration of ternary
complex at S0 = S
opt
0 , depends on ligand concentration
and affinity for the special case where A0 = B0 = L0
and Ka = Kb = KD. Thus, at different concentrations,
a scaffold can produce quantitatively identical outputs,
as measured by co-localization of its binding partners,
but qualitatively distinct outputs, because the binding
partners differ. Any scaffold is potentially multifunc-
tional, as the concentration of a scaffold can be adjusted
through regulation of gene expression. In addition, the
effective concentration of a scaffold can be adjusted with-
out changes in gene expression through post-translational
modifications, e.g., phosphorylation-dependent binding
sites on a scaffold can be turned on and off by kinases and
phosphatases, effectively changing the amount of scaffold
available for interaction with ligands.
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FIG. 3. A scaffold is potentially multifunctional. (A) Ac-
cording to the ternary-complex model, a scaffold can recruit
different ligand pairs at different scaffold concentrations. Pa-
rameters used in calculations are as follows: A0 = B0 = 0.05
µM and Ka = Kb = 5 nM (solid line); A0 = B0 = 1.0 µM
and Ka = Kb = 8.8 µM (broken line). Competition of ligand
pairs was not considered explicitly in our calculations because
competition is insignificant for this particular example. (B)
A contour plot showing log10(C
max
ab /1 µM) as a function of
ligand concentration L0 (µM) and equilibrium dissociation
constant KD (µM). We assume that Ka = Kb = KD and
A0 = B0 = L0. Along any contour line, C
max
ab is constant
while Sopt0 varies in accordance with Eq. (23).
C. Dependence of complex formation on binding
constants
Figure 4 illustrates how the maximum concentration
of ternary complex, Cmaxab , and the scaffold concentration
at which Cab = C
max
ab (S
opt
0 ) depend on the binding con-
stants that characterize ligand-scaffold interactions. In
Fig. 4A, we can see that Sopt0 increases as the equilib-
rium dissociation constant KD (Ka = Kb = KD for the
results shown in this panel) increases, or equivalently,
as affinity decreases. In Fig. 4B, we can see how Sopt0
changes as the equilibrium dissociation constant for scaf-
fold interaction with ligand A (Ka) is varied while Kb is
held constant at 5, 50, and 500 nM. The value of Sopt0 is
least sensitive to changes in Ka and Kb for small values of
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FIG. 4. Effects of binding constants on optimal scaffold con-
centration Sopt0 and maximum concentration of ternary com-
plex Cmaxab . (A) The value of Cab is plotted as the function
of S0 for three different values of KD. In these calculations,
Ka and Kb are each set equal to KD and A0 = B0 = 0.2
µM. (B) The value of Sopt0 is shown as a function of Ka for
three different values of Kb. Ligand concentrations are the
same as for panel (A). (C) The value of Cmaxab is plotted as a
function of the ratio of the equilibrium dissociation constants
(Kb/Ka). In this panel, Ka is held fixed at 5 nM and ligand
concentrations are the same as for panel (A).
Ka and Kb (i.e., for high ligand-scaffold affinities). Fig-
ure 4C shows how Cmaxab depends on Ka and Kb. In this
example, Cmaxab is affected by changes of Ka and Kb, but
large changes of Ka or Kb result in only modest changes
of Cmaxab . For example, a 100-fold increase in Kb from 5
nM (Kb/Ka = 1) to 0.5 µM (Kb/Ka = 100) results in
a only an approximate four-fold decrease of Cmaxab from
0.15 µM to 0.04 µM. As indicated by Eq. (27), the sen-
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FIG. 5. Dependence of scaffold-nucleated complex formation
on ligand concentrations according to the ternary-complex
model. (A) The amount of ternary complex Cab is plotted as
a function of total scaffold concentration S0 for three different
values of L0. In these calculations, A0 and B0 are each set
equal to L0 and Ka = Kb = 5 nM. (B) Cab vs. S0 for three
different total concentrations of ligand B (B0) with A0 held
fixed at 0.5 µM. The equilibrium dissociation constants are
the same as for panel (A).
sitivities of Cmaxab and S
opt
0 to an increase in a binding
constant is analogous to the sensitivities of these quanti-
ties to an increase in the concentration of a competitive
inhibitor or decoy receptor.
D. Dependence of complex formation on ligand
concentrations
Figure 5 illustrates how the maximum concentration
of ternary complex, Cmaxab , and the scaffold concentration
at which Cab = C
max
ab (S
opt
0 ) depend on ligand concen-
trations. The results shown in Fig. 5 complement those
of Eq. (23) and Fig. 3. In Fig. 5A, we can see that Sopt0
increases as both ligand concentrations (A0 = B0 = L0)
increase simultaneously. Increasing ligand concentrations
also increases Cmaxab . Thus, inhibition of ternary complex
formation by excess scaffold can be reversed by increas-
ing ligand concentrations. For example, 10 µM scaffold
inhibits formation of the ternary complex at L0 = 0.5
µM. In contrast, when L0 = 1.5 µM, C
max
ab is increased
by nearly three fold and there is a significant amount
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FIG. 6. The effect of cooperativity on scaffold-mediated nu-
cleation of ternary complex: Cab (µM) is plotted as a func-
tion of S0 (µM) for five different values of the cooperativity
factor φ. The solid line corresponds to independent bind-
ing of ligands A and B to the scaffold (φ = 1). The broken
line and dotted line below the solid line correspond to neg-
ativity cooperativity: φ = 0.1 and φ = 0.01, respectively.
Similarly, the broken line and dotted line above the solid line
correspond to positive cooperativity: φ = 10 and φ = 100,
respectively. Calculations are based on the following ligand
concentrations and binding constants: A0 = B0 = L0 = 0.5
µM and Ka = Kb = KD = 5 nM. In accordance with Eq. (23),
Sopt0 = L0 +KD = 0.505 µM for all curves.
of ternary complex at a 10 µM concentration of scaffold
(Fig. 5A). In Fig. 5B, we show how Cab depends on the
total scaffold concentration S0 for three different values
of B0 (0.5, 1 and 5 µM). For all three curves, the value of
A0 is the same (0.5 µM). As can be seen, when the two
ligand concentrations are different, the value of Cab can
be nearly maximal over a broad range of scaffold con-
centrations. For example, at B0 = 5.0 µM and A0 = 0.5
µM, Cab is nearly maximal for scaffold concentrations be-
tween 1 and 5 µM. Over this range, ligand B is in excess
and ligand A is limiting (i.e, nearly all A is bound to
scaffold and the amount of ternary complex is approxi-
mately equal to the concentration of ligand A). At higher
scaffold concentrations, free B is consumed and Cab be-
comes less than maximal because of the excess scaffold
effect [15, 16].
E. Cooperative binding
Cooperative binding of ligands A and B to a scaffold
is illustrated in Fig. 6. In accordance with Eq. (23), Sopt0
is independent of the value of φ. However, for φ > 1, Cab
takes on a nearly maximal value over a broader range of
scaffold concentrations. For φ < 1, the maximal value of
Cab is attenuated.
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FIG. 7. The effects of scaffold valence n on nucleation of a
complex containing n ligands (L1, . . . , Ln). The concentra-
tion of complex containing all n ligands, Cn, is plotted as a
function of the total scaffold concentration, S0, for three dif-
ferent valences: n = 2, 3 and 4. Calculations are based on
Eqs. (4) and (5) and the following parameter values: Li0 = 1
µM and Ki = 0.05 µM for all i.
F. Higher-order complexes
So far, we have considered ternary complexes nucle-
ated by a bivalent scaffold. Here, we consider scaffold-
nucleated complexes containing two or more ligands per
scaffold. In other words, we consider the reaction scheme
of Eq. 1, which is illustrated in Fig. 1A. In Fig. 7, we
show how C2, C3 and C4 depend on the total scaffold
concentration S0, where Cn is the concentration of scaf-
fold bound to n ligands. As can be seen, for a larger value
of n, the maximum value of Cn is reduced (in a controlled
comparison). In addition, the scaffold concentration at
which Cn is maximum is reduced. These results are con-
sistent with the intuition that it is more difficult to form
a scaffold-nucleated complex that contains more ligands.
The results of Fig. 7 are essentially the same as those
obtained by Heinrich et al. [17] through the analysis of
a more mechanistically detailed model, which provides
further support for the relevance of the minimalist mod-
els considered in this study. The asymmetry seen in the
curves of Fig. 7 is explained by the asymptotic limits of
|gn|, which is given by Eq. (7), as S0 approaches 0 and
∞.
G. Effects of a scaffold on an enzymatic reaction
In accordance with Eq. (30), an enzyme-scaffold com-
plex can be regarded as an effective enzyme, one that has
a different maximal rate of reaction and one that achieves
the half maximal rate at a different substrate concentra-
tion, which can be lower or higher than the correspond-
ing concentration in the absence of scaffold. Figure 8
complements these insights, showing how a scaffold that
co-localizes a substrate and enzyme can affect the initial
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FIG. 8. The effect of a scaffold on an enzymatic reaction
under the assumption of rapid equilibrium. The initial nor-
malized rate of reaction is plotted as a function of (A) total
scaffold concentration S0 (µM) and (B) total substrate con-
centration A0 (µM). In panel (A), A0 = 1 µM. The dash-dot
curve corresponds to V/(kcatB0) (Eq. (29)), the dotted curve
corresponds to V ′/(hkcatB0) (Eq. (30)), and the solid curve
corresponds to V/(kcatB0) + V
′/(hkcatB0). In panel (B), the
dash-dot curve corresponds to the case of a classical Michaelis-
Menten reaction (no scaffold). The other curves correspond
to different scaffold concentrations: 0.5 µM (dotted line), 5
µM (broken line) and 50 µM (solid line). Calculations are
based on Eqs. (10)–(15) with φ = 1 and with Eqs. (14) and
(15) each modified to include a term for the concentration of
(AB), which is taken to be AfBf/Km. The following param-
eter values were used in all calculations: Ka = Kb = 0.005
µM, Km = 0.6 µM, and B0 = 0.2 µM.
rate of enzyme-catalyzed conversion of the substrate to
product. As can be seen in Fig. 8A, a scaffold can signif-
icantly accelerate the rate of reaction relative to the sit-
uation where the reaction proceeds in the absence of the
scaffold. However, scaffold-mediated acceleration occurs
only within a certain range of scaffold concentrations.
A scaffold concentration outside this range, in the ex-
cess scaffold regime, can have the effect of inhibiting the
enzyme-catalyzed reaction. In Fig. 8B, the rate of reac-
tion is shown as a function of substrate concentration for
different concentrations of scaffold and for the case of no
scaffold. As can be seen, the dose-response curve can be
shifted by the involvement of a scaffold, and in addition,
the slope of the curve can be altered, i.e., the sensitivity
of reaction rate to a change in substrate concentration
can be altered. For the case of Fig. 8B, the effect of the
scaffold is to increase the sensitivity of the initial reaction
rate to a change in substrate concentration.
IV. DISCUSSION
Elucidating the design principles of cellular regulatory
systems is recognized as an important goal of systems
biology [35–37], which is facilitated by the tools of syn-
thetic biology [38, 39]. Understanding the design princi-
ples of scaffold-mediated nucleation of a multicomponent
complex, a motif in cell signaling [14], is important for
a number of reasons, including understanding how scaf-
fold function is conserved across species, interpreting the
functional consequences of protein copy number varia-
tion in diseases, and engineering scaffolds to have desired
properties [40].
Here, we have used minimalist models for which ana-
lytical results can be obtained to reveal principles that
govern the recruitment of ligands to a scaffold. We
have shown that the simplest model considered here,
the ternary-complex model, captures essential features
predicted by more sophisticated and mechanistically de-
tailed models, which can only be analyzed via simulation
(Fig. 2). For the the ternary-complex model, we derived
a number of analytical expressions, which can serve as
basic design equations, in that these equations can po-
tentially be used to guide the manipulation of intrinsic
scaffold properties or scaffold milieu to achieve desired ef-
fects on the system-level properties of scaffold-dependent
processes. Perhaps the most significant analytical result
is Eq. (23). Special cases of this equation have been re-
ported in studies of multivalent ligand-receptor binding.
For example, Mack et al. [29] obtained a similar equa-
tion in a study of bivalent ligand-receptor binding (cf.
Eq. (16) in Ref. [29] and Eq. (23) here in this report). In
studies specifically focused on scaffolds, earlier work has
largely relied on simulation. The parameter-dependent
nature of simulation results can lead to incomplete un-
derstanding. For example, on the basis of simulation
results, Levchenko et al. [16, 41] reported that scaffold
function is insensitive to binding constants, which is def-
initely the case in certain parameter regimes. However,
as can be seen from Eq. (23) and as illustrated in Figs. 3
and 4, binding constants can have a significant impact
on scaffold function.
For the ternary-complex model, in our presentation of
Eqs. (10)–(23), we have shown that the maximum con-
centration of the ternary complex, Cmaxab , and the scaf-
fold concentration that yields this maximum concentra-
tion, Sopt0 , depend on ligand-scaffold binding constants
and ligand concentrations (Eq. (23)). In addtion, Cmaxab ,
but not Sopt0 , depends on the cooperativity of ligand A
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and ligand B binding to the scaffold. Levchenko et al.
[16] reported that cooperativity shifts the optimal scaf-
fold concentration (see Fig. 4B in Ref. [16]). This finding
is inconsistent with the equilibrium binding properties
of a scaffold (Eq. 23). The shift of dose-response curves
seen in the study of Levchenko et al. [16] is perhaps
attributable to kinetic binding properties of a scaffold
in the specific context of a MAP kinase cascade. The
above mentioned analytical results are complemented by
the simulation results of Figs. 3–6. In our presentation
of Eqs. (1)–(9), we have shown that scaffold-mediated
nucleation depends asymmetrically on total scaffold con-
centration, which is illustrated in Fig. 7. This finding is
consistent with the simulation results of Heinrich et al.
[17] (see Fig. 8 in Ref. [17]). We also considered compet-
itive ligands and decoy receptors, the presence of which
can be mimicked by an increase in the equilibrium bind-
ing constants for ligand-scaffold interactions (Eq. (27)).
Finally, we found that a scaffold can reprogram the cat-
alytic efficiency of an enzyme (Eq. (30) and Fig. 8).
The results of Fig. 3A suggest that scaffolds could have
multiple context-dependent functions. A scaffold, de-
pending on its concentration, can nucleate distinct sets of
ligands. Thus, in a given cellular context, only a subset
of a scaffold’s known binding partners may be physio-
logically relevant. In addition, in cases where the (ef-
fective) scaffold concentration depends on the strength
of a signal, a scaffold may enable a cell to respond dif-
ferentially to signal strength. An example where effec-
tive scaffold concentration depends on signal strength
via post-translational modifications and other fast events
(and not gene expression) is provided by the model of
Goldstein et al. [33] and Faeder et al. [34] for signaling
by the high-affinity receptor for IgE antibody (FcRI). In
this model, phosphorylated receptors in ligand-induced
receptor dimers serve to co-localize two copies of the pro-
tein tyrosine kinase Syk, which is necessary for Syk au-
tophosphorylation and downstream Syk-dependent sig-
naling events. Furthermore, the number of receptor
dimers depends on the concentration of (multivalent)
ligand that induces receptor aggregation. Thus, given
the results of Fig. 3A, receptor dimers in this system,
which have a scaffold-like function, could nucleate differ-
ent signaling complexes at different ligand doses [1, 42],
with these complexes potentially eliciting different cellu-
lar responses. We are not aware of a signaling system
where scaffold concentration controls the formation of
complexes that lead to distinct cellular responses, but
given the number of binding partners of a typical signal-
ing protein, we expect that scaffold multifunctionality,
such as that illustrated in Fig. 3A, could be found.
Results such as those shown in Fig. 4C can be used
to engineer a scaffold with non-native ligand-scaffold in-
teractions to obtain a desired scaffold-dependent cellular
response to a signal, assuming ternary complex formation
correlates with the cellular response of interest. Park et
al. [5] engineered the yeast scaffold protein Ste5 to inter-
act with one of its binding partners, Ste7 or Ste11, via
a non-native protein-protein interaction. In these exper-
iments, the Ste7 or Ste11 binding site on Ste5 was dis-
rupted by a mutation of Ste5 (V763A/S861P or I504T)
and Ste5 was fused to the PDZ domain of syntrophin. In
addition, Ste7 or Ste11 was fused to the PDZ domain of
neuronal nitric oxide synthase (nNOS). The nNOS and
syntrophin PDZ domains heterodimerize with a KD of
0.6 µM [43]. In contrast, the native interaction between
Ste5 and Ste7 or Ste11 is characterized by a KD of about
0.1 µM [44, 45]. Using measured concentrations of Ste5
(35 nM), Ste11 (39 nM) and Ste7 (68 nM) reported by
Maeder et al. [44], we can calculate the effect of increas-
ing KD from 0.1 to 0.6 µM. We find that this change
is expected to cause a 15-fold decrease in the amount of
the ternary complex composed of Ste5, Ste7 and Ste11.
This prediction is consistent with the decrease in phos-
phorylation of Fus3 observed by Park et al. [5] for the
engineered Ste5-Ste7 or Ste5-Ste11 interaction.
We have focused on equilibrium properties of scaf-
folds that nucleate ternary and higher-order protein com-
plexes. We also considered the effect of a scaffold on
the rate of an enzyme-catalyzed reaction under a rapid
equilibrium assumption. The results that we have found
should be useful for understanding cellular responses
that depend on the concentration and composition of
a scaffold-nucleated complex, assuming that these re-
sponses are insensitive to the kinetics of complex for-
mation. As Locasale et al. [20, 21] and Thalhauser
and Komarova [22] have shown, the kinetics of scaffold-
mediated complex formation can have physiological rele-
vance. Thus, an important caveat of the results presented
here is the assumption of equilibrium or pseudo equilib-
rium. Another caveat is the assumption of monovalent
ligands. If the ligands that interact with a multivalent
scaffold are themselves multivalent, then complex dose-
response behavior can arise, such that complex formation
is maximal at multiple scaffold concentrations [1, 42].
An interesting future application of the results pre-
sented here might be interpretation of comparative pro-
teomics data. It has been observed that protein copy
number tends to be conserved across species [46–48]. Be-
cause the function of a scaffold is affected by the relative
abundances of the scaffold and its ligands, conservation
of relative abundances of the proteins in a “scaffold mo-
tif” would suggest conservation of function of the motif,
whereas the opposite would suggest the acquisition of a
new function or compensatory modifications of scaffold
properties and/or milieu, which could perhaps be more
easily understood or predicted in light of this report.
ACKNOWLEDGEMENTS
This work was supported by NIH grants GM076570
and RR18754, Department of Energy contract DE-AC52-
06NA25396, and NSFC grant 30870477. J.Y. thanks Dr.
Zhen Wang for helpful discussions and the Center for
Nonlinear Studies for support that made travel to Los
12
Alamos possible.
[1] W. S. Hlavacek, J. R. Faeder, M. L. Blinov, A. S. Perel-
son, and B. Goldstein, Biotechnol Bioeng 84, 783 (2003).
[2] T. Pawson and J. D. Scott, Science 278, 2075 (1997).
[3] E. A. Elion, J Cell Sci 114, 3967 (2001).
[4] M. K. Malleshaiah, V. Shahrezaei, P. S. Swain, and S. W.
Michnick, Nature, 101(2010).
[5] S. H. Park, A. Zarrinpar, and W. A. Lim, Science 299,
1061 (2003).
[6] M. Rozakis-Adcock, R. Fernley, J. Wade, T. Pawson, and
D. Bowtell, Nature 363, 83 (1993).
[7] W. Zhang, J. Sloan-Lancaster, J. Kitchen, R. P. Trible,
and L. E. Samelson, Cell 92, 83 (1998).
[8] L. E. Samelson, Annu Rev Immunol 20, 371 (2002).
[9] W. R. Burack, A. M. Cheng, and A. S. Shaw, Curr Opin
Immunol 14, 312 (2002).
[10] A. Nag, M. I. Monine, J. R. Faeder, and B. Goldstein,
Biophys J 96, 2604 (2009).
[11] W. R. Burack and A. S. Shaw, Curr Opin Cell Biol 12,
211 (2000).
[12] T. Pawson, Curr Opin Cell Biol 19, 112 (2007).
[13] A. Zeke, M. Luka´cs, W. A. Lim, and A. Reme´nyi, Trends
Cell Biol 19, 364 (2009).
[14] M. C. Good, J. G. Zalatan, and W. A. Lim, Science 332,
680 (2011).
[15] D. Bray and S. Lay, Proc Natl Acad Sci USA 94, 13493
(1997).
[16] A. Levchenko, J. Bruck, and P. W. Sternberg, Proc Natl
Acad Sci USA 97, 5818 (2000).
[17] R. Heinrich, B. G. Neel, and T. A. Rapoport, Mol Cell
9, 957 (2002).
[18] P. S. Swain and E. D. Siggia, Biophys J 82, 2928 (2002).
[19] K. E. Prehoda and W. A. Lim, Curr Opin Cell Biol 14,
149 (2002).
[20] J. W. Locasale, A. S. Shaw, and A. K. Chakraborty, Proc
Natl Acad Sci USA 104, 13307 (2007).
[21] J. W. Locasale and A. K. Chakraborty, PLoS Comput
Biol 4, e1000099 (2008).
[22] C. J. Thalhauser and N. L. Komarova, PLoS One 5,
e11568 (2010).
[23] C. J. Bashor, N. C. Helman, S. Yan, and W. A. Lim,
Science 319, 1539 (2008).
[24] S. A. Chapman and A. R. Asthagiri, Mol Syst Biol 5,
313 (2009).
[25] S. Jacobs and P. Cuatrecasas, Biochim Biophys Acta
433, 482 (1976).
[26] A. De Lean, J. M. Stadel, and R. J. Lefkowitz, J Biol
Chem 255, 7108 (1980).
[27] A. S. Perelson and C. DeLisi, Math Biosci 48, 71 (1980).
[28] B. Sulzer and A. S. Perelson, Math Biosci 135, 147
(1996).
[29] E. Mack, R. Perez-Castillejos, Z. Suo, and G. Whitesides,
Anal Chem 80, 5550 (2008).
[30] M. A. Savageau, Curr Top Cell Reg 6, 63 (1972).
[31] M. A. Savageau, Biochemical Systems Analysis: A Study
of Function and Design in Molecular Biology (Addison-
Wesley, Reading, MA, 1976).
[32] J. E. Dueber, G. C. Wu, G. R. Malmirchegini, T. S.
Moon, C. J. Petzold, A. V. Ullal, K. L. J. Prather, and
J. D. Keasling, Nat Biotechnol 27, 753 (2009).
[33] B. Goldstein, J. R. Faeder, W. S. Hlavacek, M. L. Blinov,
A. Redondo, and C. Wofsy, Mol Immunol, 1213(2002).
[34] J. R. Faeder, W. S. Hlavacek, I. Reischl, M. L. Blinov,
H. Metzger, A. Redondo, C. Wofsy, and B. Goldstein, J
Immunol 170, 3769 (2003).
[35] M. A. Savageau, Chaos 11, 142 (2001).
[36] M. E. Wall, W. S. Hlavacek, and M. A. Savageau, Nat
Rev Genet 5, 34 (2004).
[37] U. Alon, An Introduction to Systems Biology: De-
sign Principles of Biological Circuits (Chapman and
Hall/CRC, Boca Raton, FL, 2006).
[38] S. Mukherji and A. van Oudenaarden, Nat Rev Genet
10, 859 (2009).
[39] C. J. Bashor, A. A. Horwitz, S. G. Peisajovich, and W. A.
Lim, Annu Rev Biophys 39, 515 (2010).
[40] W. A. Lim, Nat Rev Mol Cell Biol 11, 393 (2010).
[41] A. Levchenko, J. Bruck, and P. W. Sternberg, Syst Biol
1, 139 (2004).
[42] A. Nag, J. R. Faeder, and B. Goldstein, IET Syst Biol 4,
334 (2010).
[43] K. Harris, R. E. Lamson, B. Nelson, T. R. Hughes, M. J.
Marton, C. J. Roberts, C. Boone, and P. M. Pryciak,
Curr Biol 11, 1815 (2001).
[44] C. I. Maeder, M. A. Hink, A. Kinkhabwala, R. Mayr,
P. I. H. Bastiaens, and M. Knop, Nat Cell Biol,
1319(2007).
[45] B. D. Slaughter, J. W. Schwartz, and R. Li, Proc Natl
Acad Sci USA 104, 20320 (2007).
[46] S. P. Schrimpf, M. Weiss, L. Reiter, C. H. Ahrens, M. Jo-
vanovic, J. Malmstro¨m, E. Brunner, S. Mohanty, M. J.
Lercher, P. E. Hunziker, R. Aebersold, C. von Mering,
and M. O. Hengartner, PLoS Biol 7, e1000048 (2009).
[47] M. Weiss, S. Schrimpf, M. O. Hengartner, M. J. Lercher,
and C. von Mering, Proteomics 10, 1297 (2010).
[48] J. M. Laurent, C. Vogel, T. Kwon, S. A. Craig, D. R.
Boutz, H. K. Huse, K. Nozue, H. Walia, M. Whiteley,
P. C. Ronald, and E. M. Marcotte, Proteomics 10, 4209
(2010).
